Development of Cefuroxime Axetil Loaded Solid Self-Nanoemulsifying Drug Delivery System with Improved Pharmacokinetic Profile

被引:0
作者
Shampa, Ishita [1 ]
Anwer, Md. Khalid [2 ]
Mirza, Mohd. A. [3 ]
Al-Shdefat, Ramadan [4 ]
Taleuzzaman, Mohamad [5 ]
Talegaokar, Sushama [1 ]
Iqbal, Zeenat [1 ]
机构
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut, Nanoformulat Res Lab, New Delhi 110062, India
[2] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut, Al Kharj 11942, Saudi Arabia
[3] New Zealand Fulvic Ltd, Mt Maunganui 3116, Tauranga, New Zealand
[4] Jadara Univ, Fac Pharm, Dept Pharmaceut Sci, Irbid, Jordan
[5] Glocal Univ, Glocal Sch Pharm, Dept Pharmaceut Chem, Sharanpur, UP, India
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2017年 / 36卷 / 08期
关键词
bioavailability; carbitol; cefuroxime axetil; cremophore; S-SNEDDS; triacetin; ORAL ABSORPTION; BIOAVAILABILITY; NANOPARTICLES; MODEL;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the current study various self-nanoemulsff3ing drug delivery systems (SNEDDS) of cefuroxime axetil (CA) were developed. Based on solubility data of CA in various components, triacetin, cremophor EL and carbitol were selected as oil, surfactant and cosurfactant, respectively. The developed CA loaded SNEDDS were evaluated for thermodynamic stability, droplet size, morphology (TEM), refractive index, viscosity, transmittance and in vitro drug release. Results showed that the mean droplet size of all self-nanoemulsifying drug delivery system were found to be in the range (23.95 to70.69 nm). All formulae also showed good optical clarity and optimum viscosity. In vitro release of cefuroxime axetil from optimized (12) self-nanoemulsifying drug delivery system formulae showed more than 84% of CA released in 10 h. The optimized self-nanoemulsifying drug delivery system was further incorporated into solid self-nanoemulsifying drug delivery system by extrusion-spheronization technique using microcrystalline cellulose and starch as a carrier. The in vivo data showed the bioavailability increased by four times in solid seff-nanoemulsifying drug delivery system compared to the other marketed preparations.
引用
收藏
页码:1553 / 1562
页数:10
相关论文
共 24 条
[1]   Development and Evaluation of a Solid Self-Nanoemulsifying Drug Delivery System for Loratadin by Extrusion-Spheronization [J].
Abbaspour, Mohammadreza ;
Jalayer, Negar ;
Makhmalzadeh, Behzad Sharif .
ADVANCED PHARMACEUTICAL BULLETIN, 2014, 4 (02) :113-119
[2]   Formulation of Self-Nanoemulsifying Drug Delivery System for Telmisartan with Improved Dissolution and Oral Bioavailability [J].
Ahmad, Javed ;
Kohli, Kanchan ;
Mir, Showkat R. ;
Amin, Saima .
JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2011, 32 (07) :958-968
[3]   Development and evaluation of PLGA polymer based nanoparticles of quercetin [J].
Anwer, Md. Khalid ;
Al-Mansoor, Mohammed A. ;
Jamil, Shahid ;
Al-Shdefat, Ramadan ;
Ansari, Mohammad Nazam ;
Shakeel, Faiyaz .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 92 :213-219
[4]   Water soluble binary and ternary complexes of diosmin with β-cyclodextrin: Spectroscopic characterization, release studies and anti-oxidant activity [J].
Anwer, Md Khalid ;
Jamil, Shahid ;
Ansari, Mohammad Javed ;
Al-Shdefat, Ramadan ;
Ali, Bahaa E. ;
Ganaie, Majid Ahmad ;
Abdel-Kader, Maged S. ;
Shakeel, Faiyaz .
JOURNAL OF MOLECULAR LIQUIDS, 2014, 199 :35-41
[5]   A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability [J].
Chai, Fujuan ;
Sun, Linlin ;
Ding, Yafei ;
Liu, Xiaoqing ;
Zhang, Yajie ;
Webster, Thomas J. ;
Zheng, Chunli .
NANOMEDICINE, 2016, 11 (14) :1801-1816
[6]   LIPID MICROEMULSIONS FOR IMPROVING DRUG DISSOLUTION AND ORAL ABSORPTION - PHYSICAL AND BIOPHARMACEUTICAL ASPECTS [J].
CONSTANTINIDES, PP .
PHARMACEUTICAL RESEARCH, 1995, 12 (11) :1561-1572
[7]   Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs [J].
Gershanik, T ;
Benita, S .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :179-188
[8]  
Ghebre-Sellassie I., 1989, PHARM PELLETIZATION, V1, P1
[9]  
Karim A., 1994, PHARM RES, V2, P368
[10]  
Krishnaiah Y.S.R., 2010, Journal of Bioequivalence and Bioavailability, V2, P28, DOI [10.4172/jbb.1000027, DOI 10.4172/JBB.1000027]